vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Metallus Inc. (MTUS). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $267.3M, roughly 1.8× Metallus Inc.). Metallus Inc. runs the higher net margin — -5.3% vs -10.1%, a 4.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 11.1%). Metallus Inc. produced more free cash flow last quarter ($-37.2M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -8.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CLOV vs MTUS — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.8× larger
CLOV
$487.7M
$267.3M
MTUS
Growing faster (revenue YoY)
CLOV
CLOV
+33.6% gap
CLOV
44.7%
11.1%
MTUS
Higher net margin
MTUS
MTUS
4.8% more per $
MTUS
-5.3%
-10.1%
CLOV
More free cash flow
MTUS
MTUS
$31.8M more FCF
MTUS
$-37.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-8.8%
MTUS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
MTUS
MTUS
Revenue
$487.7M
$267.3M
Net Profit
$-49.3M
$-14.3M
Gross Margin
2.2%
Operating Margin
-10.1%
-7.7%
Net Margin
-10.1%
-5.3%
Revenue YoY
44.7%
11.1%
Net Profit YoY
-123.2%
33.2%
EPS (diluted)
$-0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MTUS
MTUS
Q4 25
$487.7M
$267.3M
Q3 25
$496.6M
$305.9M
Q2 25
$477.6M
$304.6M
Q1 25
$462.3M
$280.5M
Q4 24
$337.0M
$240.5M
Q3 24
$331.0M
$227.2M
Q2 24
$356.3M
$294.7M
Q1 24
$346.9M
$321.6M
Net Profit
CLOV
CLOV
MTUS
MTUS
Q4 25
$-49.3M
$-14.3M
Q3 25
$-24.4M
$8.1M
Q2 25
$-10.6M
$3.7M
Q1 25
$-1.3M
$1.3M
Q4 24
$-22.1M
$-21.4M
Q3 24
$-9.2M
$-5.9M
Q2 24
$7.4M
$4.6M
Q1 24
$-19.2M
$24.0M
Gross Margin
CLOV
CLOV
MTUS
MTUS
Q4 25
2.2%
Q3 25
11.4%
Q2 25
10.6%
Q1 25
7.8%
Q4 24
4.5%
Q3 24
24.5%
5.3%
Q2 24
30.3%
8.2%
Q1 24
23.6%
15.7%
Operating Margin
CLOV
CLOV
MTUS
MTUS
Q4 25
-10.1%
-7.7%
Q3 25
-4.9%
3.6%
Q2 25
-2.2%
2.8%
Q1 25
-0.3%
1.0%
Q4 24
-6.4%
-10.1%
Q3 24
-2.7%
-3.1%
Q2 24
2.0%
2.1%
Q1 24
-6.5%
9.3%
Net Margin
CLOV
CLOV
MTUS
MTUS
Q4 25
-10.1%
-5.3%
Q3 25
-4.9%
2.6%
Q2 25
-2.2%
1.2%
Q1 25
-0.3%
0.5%
Q4 24
-6.6%
-8.9%
Q3 24
-2.8%
-2.6%
Q2 24
2.1%
1.6%
Q1 24
-5.5%
7.5%
EPS (diluted)
CLOV
CLOV
MTUS
MTUS
Q4 25
$-0.34
Q3 25
$0.19
Q2 25
$0.09
Q1 25
$0.03
Q4 24
$-0.46
Q3 24
$-0.13
Q2 24
$0.10
Q1 24
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MTUS
MTUS
Cash + ST InvestmentsLiquidity on hand
$78.3M
$156.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$686.0M
Total Assets
$541.0M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MTUS
MTUS
Q4 25
$78.3M
$156.7M
Q3 25
$191.5M
Q2 25
$190.8M
Q1 25
$180.3M
Q4 24
$194.5M
$240.7M
Q3 24
$288.0M
$254.6M
Q2 24
$254.8M
$272.8M
Q1 24
$208.3M
$278.1M
Total Debt
CLOV
CLOV
MTUS
MTUS
Q4 25
Q3 25
$0
Q2 25
$0
Q1 25
$5.4M
Q4 24
$5.4M
Q3 24
$13.2M
Q2 24
$13.2M
Q1 24
$13.2M
Stockholders' Equity
CLOV
CLOV
MTUS
MTUS
Q4 25
$308.7M
$686.0M
Q3 25
$340.9M
$697.7M
Q2 25
$344.2M
$690.0M
Q1 25
$336.1M
$686.1M
Q4 24
$341.1M
$690.5M
Q3 24
$342.2M
$712.7M
Q2 24
$324.9M
$736.3M
Q1 24
$292.5M
$739.3M
Total Assets
CLOV
CLOV
MTUS
MTUS
Q4 25
$541.0M
$1.1B
Q3 25
$559.7M
$1.2B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.1B
Q3 24
$653.0M
$1.1B
Q2 24
$674.2M
$1.1B
Q1 24
$671.8M
$1.2B
Debt / Equity
CLOV
CLOV
MTUS
MTUS
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.01×
Q4 24
0.01×
Q3 24
0.02×
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MTUS
MTUS
Operating Cash FlowLast quarter
$-66.9M
$-1.9M
Free Cash FlowOCF − Capex
$-69.0M
$-37.2M
FCF MarginFCF / Revenue
-14.1%
-13.9%
Capex IntensityCapex / Revenue
0.4%
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$-93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MTUS
MTUS
Q4 25
$-66.9M
$-1.9M
Q3 25
$12.1M
$22.0M
Q2 25
$5.4M
$34.8M
Q1 25
$-16.3M
$-38.9M
Q4 24
$34.8M
$13.9M
Q3 24
$50.0M
$-15.3M
Q2 24
$44.8M
$8.3M
Q1 24
$25.9M
$33.4M
Free Cash Flow
CLOV
CLOV
MTUS
MTUS
Q4 25
$-69.0M
$-37.2M
Q3 25
$11.4M
$-6.4M
Q2 25
$4.8M
$17.0M
Q1 25
$-16.5M
$-66.4M
Q4 24
$33.3M
$-1.3M
Q3 24
$49.6M
$-32.9M
Q2 24
$44.4M
$-5.8M
Q1 24
$25.5M
$16.0M
FCF Margin
CLOV
CLOV
MTUS
MTUS
Q4 25
-14.1%
-13.9%
Q3 25
2.3%
-2.1%
Q2 25
1.0%
5.6%
Q1 25
-3.6%
-23.7%
Q4 24
9.9%
-0.5%
Q3 24
15.0%
-14.5%
Q2 24
12.5%
-2.0%
Q1 24
7.3%
5.0%
Capex Intensity
CLOV
CLOV
MTUS
MTUS
Q4 25
0.4%
13.2%
Q3 25
0.1%
9.3%
Q2 25
0.1%
5.8%
Q1 25
0.0%
9.8%
Q4 24
0.5%
6.3%
Q3 24
0.1%
7.7%
Q2 24
0.1%
4.8%
Q1 24
0.1%
5.4%
Cash Conversion
CLOV
CLOV
MTUS
MTUS
Q4 25
Q3 25
2.72×
Q2 25
9.41×
Q1 25
-29.92×
Q4 24
Q3 24
Q2 24
6.04×
1.80×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MTUS
MTUS

Industrial Market Sector$95.3M36%
Manufactured Components$67.8M25%
Aerospace And Defense$39.6M15%
Seamless Mechanical Tubing$31.3M12%
Energy Market Sector$18.3M7%
Other$11.3M4%
Other Market Sector$3.7M1%

Related Comparisons